Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Finance
Cardiovascular medical device company reports sales of $16.3 million
October 23rd, 2005
Possis Medical, Inc., (POSS) reported sales of $16.3 million for the fourth quarter ended July 31, 2005, versus $20.0 million in the year-ago period, and $15.1 million in the third quarter of fiscal 2005. U.S. AngioJet Rheolytic Thrombectomy System sales for the fourth quarter were $15.6 million, compared with $19.7 million 1 year ago. For the fiscal year ended July 31, 2005, Possis reported sales of $65.1 million, versus $72.4 million in the prior year. Fiscal 2005 U.S. AngioJet System sales were $63.0 million, compared to $70.8 million in 2004. Net income per diluted share for the 2005 fourth quarter was $0.07 versus $0.18 in the prior-year period....
Source: Medical Letter on the CDC & FDA (2005-10-23)
|
